A Randomized, Open-label, Multiple Dose, Three-treatment, Three-period, Six-sequence Williams Design to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration in Healthy Volunteers

Trial Profile

A Randomized, Open-label, Multiple Dose, Three-treatment, Three-period, Six-sequence Williams Design to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration in Healthy Volunteers

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 03 Feb 2016

At a glance

  • Drugs Udenafil (Primary) ; Bosentan
  • Indications Benign prostatic hyperplasia; Erectile dysfunction; Portal hypertension; Pulmonary arterial hypertension
  • Focus Pharmacokinetics
  • Sponsors Dong-A Pharmaceutical
  • Most Recent Events

    • 27 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 31 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top